Kamitaki, B. K., Janmohamed, M., Kandula, P., Elder, C., Mani, R., Wong, S., Perucca, P., O’Brien, T. J., Lin, H., Heiman, G. A., & Choi, H. (2021). Clinical and EEG factors associated with antiseizure medication resistance in idiopathic generalized epilepsy. Epilepsia, 63(1), 150–161. Portico. https://doi.org/10.1111/epi.17104

Youngerman, B. E., Mahajan, U. V., Dyster, T. G., Srinivasan, S., Halpern, C. H., McKhann, G. M., & Sheth, S. A. (2021). Cost‐effectiveness analysis of responsive neurostimulation for drug‐resistant focal onset epilepsy. Epilepsia, 62(11), 2804–2813. Portico. https://doi.org/10.1111/epi.17049

Kroopnick, A., Jia, D. T., Rimmer, K., Namale, V. S., Kim, C., Ofoezie, U., & Thakur, K. T. (2021). Clinical use of steroids in viral central nervous system (CNS) infections: three challenging cases. Journal of NeuroVirology, 27(5), 727–734. https://doi.org/10.1007/s13365-021-01008-5

Denison, T., Koubeissi, M., Krook-Magnuson, E., Mogul, D., Worrell, G., & Schevon, C. (2021). Stimulating Solutions for Intractable Epilepsy. Epilepsy Currents, 21(5), 315–319. https://doi.org/10.1177/15357597211012466

Bank, A. M., Billakota, S., Bateman, L. M., Hamberger, M. J., Cole, J., McKhann, G. M., Feldstein, N., & Schevon, C. A. (2021). Electrically stimulated auras as a potential biomarker of the epileptogenic zone. Epilepsy & Behavior, 122, 108116. https://doi.org/10.1016/j.yebeh.2021.108116

Meador, K. J., Cohen, M. J., Loring, D. W., May, R. C., Brown, C., Robalino, C. P., Matthews, A. G., Kalayjian, L. A., Gerard, E. E., Gedzelman, E. R., Penovich, P. E., Cavitt, J., Hwang, S., Sam, M., Pack, A. M., French, J., Tsai, J. J., Pennell, P. B., … Miller, D. (2021). Two-Year-Old Cognitive Outcomes in Children of Pregnant Women With Epilepsy in the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs Study. JAMA Neurology, 78(8), 927. https://doi.org/10.1001/jamaneurol.2021.1583